Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$3 Mln
Revenue (TTM)
$8 Mln
Net Profit (TTM)
$0 Mln
ROE
-2.7 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
1.9
Industry P/E
140.42
EV/EBITDA
0.4
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$-12.6
Face value
--
Shares outstanding
2,496,860
CFO
$-27.94 Mln
EBITDA
$-32.57 Mln
Net Profit
$-46.99 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
iSpecimen Inc (ISPC)
| -60.1 | -6.8 | -18.5 | -86.1 | -73.3 | -- | -- |
|
BSE Sensex
| 3.7 | -1.6 | 9.6 | 5.9 | 14.3 | 19.1 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
|---|---|---|---|
|
iSpecimen Inc (ISPC)
| -73.2 | -63.6 | -82.4 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
iSpecimen Inc (ISPC)
|
1.1 | 3.1 | 8.5 | -15.6 | -110.7 | -389.8 | -- | 1.9 |
| 225.6 | 8,208.4 | 824.5 | 196.8 | 16.9 | 45 | 42.6 | 17.8 | |
| 5.5 | 10,401.0 | 0.0 | -791.0 | -- | -41.6 | -- | 5.8 | |
| 184.6 | 8,308.4 | 995.6 | 76.1 | 8.1 | 25.2 | 111.4 | 25.9 | |
| 23.7 | 8,200.0 | 1,017.5 | -319.7 | -28.3 | -32.6 | -- | 8.0 | |
| 69.5 | -- | 1,450.1 | 4.0 | 4.8 | 0.2 | 369.2 | 0.0 | |
| 104.8 | 9,041.9 | 1,243.0 | 67.9 | 10.6 | -- | 78 | 4.3 | |
| 176.8 | 10,277.2 | 1,551.8 | 227.3 | 19.6 | 19.6 | 46.3 | 8.5 | |
| 98.9 | 8,697.7 | 1,642.7 | 196.7 | 17.5 | 36.3 | 47.1 | 14.3 | |
| 23.7 | 10,325.9 | 1,787.9 | -450.7 | -29.5 | -14.1 | -- | 3.2 |
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access... to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; Solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and Hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. The company serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts. Address: 8 Cabot Road, Woburn, MA, United States, 02420 Read more
CEO, CFO, Treasurer & Director
Ms. Tracy Wilson Curley
Senior Vice President of Operations
Ms. Leslie Hoyt
Headquarters
Woburn, MA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of iSpecimen Inc (ISPC) stood at $ 16 Mln as on 31-Mar-25
The share price of iSpecimen Inc (ISPC) is $1.06 (NASDAQ) as of 13-Jun-2025 16:00 EDT. iSpecimen Inc (ISPC) has given a return of -73.27% in the last 3 years.
iSpecimen Inc (ISPC) has a market capitalisation of $ 3 Mln as on 12-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of iSpecimen Inc (ISPC) is 1.86 times as on 12-Jun-2025, a 76% discount to its peers’ median range of 7.82 times.
Since, TTM earnings of iSpecimen Inc (ISPC) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the iSpecimen Inc (ISPC) and enter the required number of quantities and click on buy to purchase the shares of iSpecimen Inc (ISPC).
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; Solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and Hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. The company serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts. Address: 8 Cabot Road, Woburn, MA, United States, 02420
The CEO & director of Ms. Tracy Wilson Curley. is iSpecimen Inc (ISPC), and CFO & Sr. VP is Ms. Leslie Hoyt.
There is no promoter pledging in iSpecimen Inc (ISPC).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,040
|
|
|
1,033
|
|
|
1,028
|
|
|
970
|
|
|
904
|
|
|
870
|
|
|
831
|
|
|
821
|
|
|
820
|
| iSpecimen Inc (ISPC) | Ratios |
|---|---|
|
Return on equity(%)
|
-389.82
|
|
Operating margin(%)
|
-110.66
|
|
Net Margin(%)
|
-184.54
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of iSpecimen Inc (ISPC) was $0 Mln.
$-0.07
(
